Jia Li

Jia Li is a seasoned professional in biopharmaceutical business development, currently serving as Senior Director at Guardant Health since July 2017, where efforts focus on accelerating clinical development programs for pharmaceutical companies through advanced diagnostic tests. Prior to this role, Jia held the position of Senior Director of Business Development for the GuardantConnect Global Test Access Program at Cure Forward from September 2015 to June 2017, a platform aimed at enhancing access to precision medicine for cancer patients. Earlier experience includes serving as Vice President of Clinical Trial Imaging Business Development at M2S from June 2008 to March 2013, providing image management services for clinical trials across various therapeutic areas. Jia Li holds a Master's degree in Biology from the University of California, Berkeley, and a double Bachelor's degree in Biology and Economics from the University of California, Santa Cruz.